Status:
COMPLETED
Uveitis Gene-Expression Profiling
Lead Sponsor:
Oregon Health and Science University
Conditions:
Uveitis
Eligibility:
All Genders
21+ years
Brief Summary
Uveitis is a group of troublesome diseases that collectively represent a cause of blindness comparable to diabetes. Most forms of uveitis are either infectious or immune-mediated. The investigators pr...
Eligibility Criteria
Inclusion
- The study group will include patients aged 21 years or older attending the Uveitis Clinic at the Casey Eye Institute at OHSU who have uveitis of the following subtypes:
- ankylosing spondylitis
- sarcoidosis
- Behçet's disease
- toxoplasmosis
- herpetic acute retinal necrosis; AND
- idiopathic uveitis
- Another group of patients, also aged 21 years or more, with the following diseases but no uveitis, will be recruited from the Rheumatology Clinic at OHSU as follows:
- ankylosing spondylitis
- sarcoidosis; AND
- Behçet's disease
- The study group will also include 30 normal control volunteers aged 21 years or older.
Exclusion
- Special/vulnerable subject populations (e.g., mentally impaired persons and children) will not be enrolled.
Key Trial Info
Start Date :
June 1 2005
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
Estimated Enrollment :
280 Patients enrolled
Trial Details
Trial ID
NCT00874471
Start Date
June 1 2005
Last Update
April 9 2014
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Oregon Health & Science University
Portland, Oregon, United States, 97239-3098